Clinical trials
Pancreatic Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 6 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Unknown status | 18 |
| Not yet recruiting | 9 |
| Recruiting | 8 |
| Withdrawn | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Changhai Hospital | 5 |
| Gang Chen | 2 |
| IHU Strasbourg | 2 |
| IRCCS San Raffaele | 2 |
| Stanford University | 2 |
| The Third Xiangya Hospital of Central South University | 2 |
| Aalborg University Hospital | 1 |
| Air Force Military Medical University, China | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Diseases | 60 |
| Pancreatic Neoplasms | 12 |
| Biliary Tract Diseases | 6 |
| Postoperative Complications | 6 |
| Digestive System Diseases | 5 |
| Liver Diseases | 5 |
| Pancreatitis | 5 |
| Cystic Fibrosis | 3 |
| Gallbladder Diseases | 3 |
| Pancreatic Cyst | 3 |
Trials
Showing 26 to 50 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.